ArticleChemistry & biodiversity2026
Bioactive Compounds and Antidiabetic Properties of Launaea mucronata Hydroethanolic Extract: Phytochemical and Pharmacological Insights.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Launaea mucronata has been traditionally used in folk medicine worldwide for managing various diseases. This study investigated the phytochemical composition and biological activities of the hydroethanolic extract of L. mucronata aerial parts. Total phenolic and flavonoid contents were 63.77 ± 0.21 mg GAE/g and 20.91 ± 1.56 mg QE/g, respectively. Phytochemical investigation yielded lupeol (1) and β-sitosterol (2) from the n-hexane fraction; ethyl caffeate (3) and apigenin (4) from the dichloromethane fraction; apigenin (4), luteolin (5), and apigenin-7-O-glucuronide (6) from the ethyl acetate fraction. Antioxidant capacity, assessed via 2,2‑diphenyl‑1‑picrylhydrazyl (DPPH, 109.30 ± 0.75 mg AAE/g) and phosphomolybdenum (119.18 ± 0.93 mg AAE/g) assays, was notable. The extract also showed significant antidiabetic potential, inhibiting α-glucosidase (IC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.